0001578563-24-000173.txt : 20240320
0001578563-24-000173.hdr.sgml : 20240320
20240320184134
ACCESSION NUMBER: 0001578563-24-000173
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHURCH KATRINA J
CENTRAL INDEX KEY: 0001204391
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37844
FILM NUMBER: 24768963
MAIL ADDRESS:
STREET 1: 3290 WEST BAYSHORE ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioventus Inc.
CENTRAL INDEX KEY: 0001665988
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 810980861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 474-6700
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
wk-form4_1710974485.xml
FORM 4
X0508
4
2024-03-15
0
0001665988
Bioventus Inc.
BVS
0001204391
CHURCH KATRINA J
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM
NC
27703
0
1
0
0
SVP & Chief Compliance Officer
0
Class A Common Stock
2024-03-15
4
S
0
1217
5.46
D
14067
D
Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 14, 2024 pursuant to a standing 10b5-1 instruction.
The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple stockholders in multiple transactions at prices ranging from $5.13 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.
/s/ Anthony D'Adamio, Attorney-in-Fact
2024-03-20